Which type of training did you complete?

Webinar

You must read and accept the terms and conditions to access the webinar. Please read the following program information and click on the button to begin the session.

Accept terms and conditions to view video



What is SCOPE of Pain?

Chronic pain affects approximately 100 million in the US, making it one of the most common reasons for patients to seek medical care. Unfortunately, pain management, including the appropriate use of opioids, is not well covered in medical training. Moreover, there are inadequate numbers of pain management specialists to help generalist providers manage these patients.

Partly in response to the problem of under-treatment of pain, over the past decade there has been a four-fold increase in opioid prescribing. During the same time period there was a four-fold increase in unintentional opioid overdose deaths and a five-fold increase in substance abuse treatment admissions for prescription opioid addiction.

Providers who prescribe ER/LA opioid analgesics to treat chronic pain are in a key position to balance the benefits and risks of chronic opioid therapy (COT). However, providers struggle with the need to assist their patients with adequate management of chronic pain while confronting the risks associated with opioid prescribing. Our educational program looks to address that need.

The SCOPE of Pain webinar is designed to help you safely and effectively manage patients with chronic pain, when appropriate, with opioid analgesics.

The FDA has mandated manufacturers of extended release/long-acting (ER/LA) opioid analgesics, as part of a comprehensive Risk Evaluation and Mitigation Strategy (REMS), to make available comprehensive prescriber education in the safe use of these medications based on the FDA curriculum known as the Blueprint for Prescriber Education for Extended Release and Long-Acting Opioid(ER/LA) Analgesics. Our curriculum covers all aspects of this blueprint and more to provide a comprehensive educational program.

Faculty

Daniel P. Alford, MD, MPH, FACP, FASAM (Course Director)
Associate Professor of Medicine
Boston University School of Medicine
Boston Medical Center

Target audience

Physicians, nurse practitioners, registered nurses, nurses, physician assistants, dentists, and pharmacists

Educational objectives

At the conclusion of this activity, participants will be able to:

  • Employ appropriate assessment, monitoring and documentation strategies to meet best practice standards and medico-legal requirements when treating patients with chronic opioid therapy (COT)
  • Apply a practical framework for decision-making on the initiation, dosage modification, and discontinuation of opioid analgesics in the treatment of chronic pain
  • Employ consistent practice tools to adequately assess risk in patients being considered for COT and to effectively manage COT
  • Confidently counsel patients and caregivers about the safe use of opioid medications and communicate about the need for close monitoring
  • Effectively communicate with patients whom they suspect may be misusing opioid analgesics
  • Demonstrate increased understanding of general- and product-specific information of ER/LA opioid analgesics

Accreditation

Physicians

Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live internet activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Contact Hours: 2.5, all of which is pharmacology credit-worthy

Nurses will receive contact hours after completion of a post-test and evaluation.

AAFP

This Live activity, SCOPE of Pain: Safe & Competent Opioid Prescribing Education, with a beginning date of 11/14/2014, has been reviewed and is acceptable for up to 2.00 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part 2

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Partners

This activity was planned in collaboration with our national partners, the Council of Medical Specialty Societies and the Federation of State Medical Boards.

Grant support

This educational activity is supported by an independent educational grant from the Extended-Release/Long-Acting Opioid Analgesic REMS Program Companies. Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Extended-Release/Long-Acting Opioid Analgesics REMS education requirements issued by the US Food & Drug Administration.

Disclosure policy

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Faculty

Daniel P. Alford, MD, MPH, FACP, FASAM (Course Director)
Associate Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regard to commercial support.
dan.alford@bmc.org

Colleen Labelle, RN, CARN (CNE Course Advisor)
Department of Internal Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regard to commercial support.
colleen.labelle@bmc.org

Original Content Development
Seddon Savage, MD, MS, FASAM, Dartmouth Medical School
Dr. Savage has nothing to disclose with regards to commercial support.
Lynn Webster, MD, FACPM, FASAM, CRI-Lifetree
Dr. Webster is a consultant for Covidien Mallinckrodt, Medtronic, Nektar Therapeutics, and Salix Pharmaceuticals.

Planning Committee
Patti-Ann Collins, DNP, MSN/MBA, RN, Lead Nurse Planner, BUSM; Ilana Hardesty, Program Operations Manager, BUSM; Joanna Krause, Grants Manager, BUSM; Colleen Labelle, RN, Nursing Course Advisor, BUSM; Stephen Wyatt, DO, independent reviewer; Jason Worcester, MD, independent reviewer
Planning committee members have nothing to disclose with regard to commercial support.

Advisory Committee
Norman Kahn, MD, Executive Vice-President and CEO, Council of Medical Specialty Societies
Stancel Riley, MD, Lecturer on Surgery, Harvard Medical School and Research Associate, Department of Health Policy Management, Harvard School of Public Health
Lisa Robin, Chief Advocacy Officer, Federation of State Medical Boards
Advisory committee members have nothing to disclose with regard to commercial support.

Off-label/investigational uses

This presentation does include discussion of the off-label use of sublingual buprenorphine to treat pain. Sublingual buprenorphine has been FDA approved for addiction treatment but not pain treatment. This presentation does include discussion of the off-label use of clonidine and tizanidine to treat opioid withdrawal symptoms. Clonidine and tizanidine are not FDA approved for this use.

Disclaimer

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

Accept terms and conditions to view video

After watching the video, create a SCOPE of Pain user account or log in to your existing account to claim credit:

Continue

Boston University Council of Medical Specialty Societies Federation of State Medican Boards